From Dr H Vaghadia and Dr M Spittle
The Middlesex Hospital. London WI Sir, Rowland Payne (1981) has described three cases of a previously unrecognized syndrome consisting of Horner's syndrome, ipsilateral vocal cord palsy and ipsilateral phrenic nerve palsy. Amin (1983) has reported a fourth case. We would like to report a further case in which postmortem findings have been documented for the first time.
A 64-year-old woman presented in 1961 with carcinoma of the left breast. In February 1981, after a disease-free interval of nearly 20 years, she presented with left shoulder pain and a hoarse voice. Clinical assessment revealed a left Horner's syndrome, a left vocal cord palsy and a paralysed left hemidiaphragm. Over the following ten months the pain in her left shoulder and arm became much worse and was associated with a motor and sensory deficit affecting the territory of C7, C8 and TI. Palpation of the supraclavicular fossa and X-ray of the cervical spine was normal at :all times. The pain was largely resistant to tamoxifen and analgesia as well as radiotherapy to an associated left apical mass. In December 1981 a left posterior rhizotomy (C3, C4 and C5), a right anterolateral cordotomy and posterior rhizotomy (C2 and C3) were performed and almost complete relief of pain was achieved. This lasted until the last two weeks of her life when she developed painful bony secondaries in the left scapula. In April 1982, 13 months after the onset of the syndrome, she succumbed.
At post-mortem examination, there was a large secondary deposit in the apex of the left lung which extended into the adjacent chest wall and involved the left brachial plexus. Secondary deposits were present in both lungs, left parietal pericardium, ovary and pouch of Douglas. No metastases were found at the level of the sixth cervical vertebra, in the intervertebral foramina or in the brain.
The site of the lesion in our patient was shown at post-mortem to be at the thoracic inlet. All five patients reported with this condition have had shoulder pain. In our patient shoulder pain was very severe and its control was the main aim of treatment. Non-steroidal anti-inflammatory agents, opiates as well as radiotherapy were ineffective. Mantell (1973, 1982) has suggested that inclusion of the spinal canal in the irradiated fields may be of benefit. He cites Pancoast's syndrome as a model where infiltration of the intervertebral foramina may be responsible for shoulder pain. Evidence of such infiltration was lacking on post-mortem examination of our case. Our patient was treated by cordotomy and posterior rhizotomy with good result. Escape from analgesia occurred immediately prior to death. A possible explanation for this is that some pain fibres may run up the posterior nerve root to the ganglion and then run peripherally again, finally reaching the cord via the anterior root (Connolly 1982) . Therefore, if pain relief is not achieved by division of the posterior root alone, it may be necessary to divide the anterior root as well. However, in our case it is more likely that the return of shoulder pain in the last fortnight was due to painful bony secondaries in the scapula. Lundberg (1965) found that two-thirds of patients with mild shoulder restriction improved and only one-fifth of patients with severe shoulder restriction improved following hydro-static distension of the shoulder joint. Reeves (1966) used serial distension of the shoulder as treatment in only 2 patients and these took three months to recover fully. There were no data on the duration of the disease in either paper and there were no controls, so it is possible that the improvement seen might be due to the natural history of the disease.
We are currently conducting a controlled study of hydrostatic distension in the treatment of adhesive capsulitis in my department and hope to be able to give a definitive answer in due course. In the meantime, I have to reiterate that the value of this treatment is not proved. Lack of understanding of two fundamental mechanisms in AlP hampers the development of a single, universally-effective treatment for the acute attack. Firstly, the mechanism by which the 'porphyrinogenic' substances initiate the acute attack of AlP is not fully elucidated. They are thought to induce aminolaevulinic acid synthetase (ALA-S) activity, predominantly in the liver where the majority of the excess production of aminolaevulinic acid (ALA) and porphobilinogen (PBG) occurs (McColl et al. 1981) . None of the currently advocated treatments is universally effective in reducing ALA-S activity.
The second difficulty is that the mechanism by which the abdominal, psychiatric and neurological symptoms are mediated remains unexplained. ALA and PBG have been implicated as neurotoxins, though, as was pointed out by Yeung Laiwah et al., infusion of these substances does not cause the typical symptoms of the acute attack: The fact that there are hormonal systems common to gut and nervous tissue has obviously hot been missed in Glasgow. The discussion paper alludes to attempts to influence one such system, the endorphin/opiate receptor system.
In Sweden, standard treatment of the acute attack of AlP remains the administration of large quantities of carbohydrate, although some limited experience with infusions of haematin has been gained (Lithner 1982) . Most patients with an established acute attack vomit copiously and cannot retain the large volumes of Hycal or glucose solutions that they are required to take. All the patients admitted to the Central Hospital in Boden in an acute attack had been vomiting for at least 24 hours before allowing themselves to be admitted. Thus most patients must be administered their carbohydrate in the form of glucose infusions.
The hyponatraemia that may occur in the acute attack of AlP is, at least in part, caused by the inappropriate secretion of antidiuretic hormone (Hellman et al. 1962) . The hypovolaemia that also occurs demands fluid replacement with saline and thus the infusion of large volumes of glucose solutions with little or no electrolyte content may be dangerous. The ability of the infused glucose to increase hepatocellular glucose uptake may also be questioned. Transient glucose intolerance may be seen (Waxman et al. 1967 ) and appears to be due to increased insulin resistance at receptor level that will reduce glucose uptake by the hepatocyte.
Assuming the effect of glucose to be mediated by the suppression of ALA-S activity, a direct release of glucose within the cell may be more effective, thereby allowing it to penetrate the mitochondrion more rapidly in order to exert its effect on the enzyme. To this end, together with Dr K Oberg of the University of Uppsala, I have tried treating patients with acute attacks of AlP with glucagon (Forrest & Oberg 1982) . This hormone was administered both intravenously and subcutaneously to 3 patients during five mild to moderate attacks of AlP. The dose was adjusted to maintain hyperglycaemia at or above 7 mrnol/l, which was achieved in. four of the five attacks. During the fifth attack the patient remained normoglycaemic. All attacks settled within 3-7 days, comparable to the time taken for similar attacks in these same patients to settle when treated by glucose infusions.
It was appreciated that hepatic stores of glycogen might well be depleted by the time the glucagon treatment was started, so the patients in
